Ocean Biomedical, Inc. (PNK: OCEA) Stock Competitors & Peer Comparison

Ocean Biomedical, Inc. (PNK: OCEA) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OCEA stands at 237.3K. In comparison, SGMO has a market cap of 30.7M. Regarding current trading prices, OCEA is priced at $0.00 on the PNK, while SGMO trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OCEA currently has a P/E ratio of N/A, whereas SGMO's P/E ratio is -0.20. In terms of profitability, OCEA's ROE is +0.04%, compared to SGMO's ROE of +66.86%. Regarding short-term risk, OCEA is more volatile compared to SGMO. This indicates higher risk in terms of short-term price fluctuations for OCEA.Check SGMO's competition here

Ocean Biomedical, Inc. (PNK: OCEA) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OCEA stands at 237.3K. In comparison, ADTX has a market cap of 3.7M. Regarding current trading prices, OCEA is priced at $0.00 on the PNK, while ADTX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OCEA currently has a P/E ratio of N/A, whereas ADTX's P/E ratio is N/A. In terms of profitability, OCEA's ROE is +0.04%, compared to ADTX's ROE of +9.26%. Regarding short-term risk, OCEA is more volatile compared to ADTX. This indicates higher risk in terms of short-term price fluctuations for OCEA.Check ADTX's competition here

Ocean Biomedical, Inc. (PNK: OCEA) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OCEA stands at 237.3K. In comparison, ITRMF has a market cap of 2.7M. Regarding current trading prices, OCEA is priced at $0.00 on the PNK, while ITRMF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OCEA currently has a P/E ratio of N/A, whereas ITRMF's P/E ratio is -0.07. In terms of profitability, OCEA's ROE is +0.04%, compared to ITRMF's ROE of +4.42%. Regarding short-term risk, OCEA is more volatile compared to ITRMF. This indicates higher risk in terms of short-term price fluctuations for OCEA.Check ITRMF's competition here

Ocean Biomedical, Inc. (PNK: OCEA) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OCEA stands at 237.3K. In comparison, CASIF has a market cap of 2.6M. Regarding current trading prices, OCEA is priced at $0.00 on the PNK, while CASIF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OCEA currently has a P/E ratio of N/A, whereas CASIF's P/E ratio is -0.05. In terms of profitability, OCEA's ROE is +0.04%, compared to CASIF's ROE of +2.04%. Regarding short-term risk, OCEA is more volatile compared to CASIF. This indicates higher risk in terms of short-term price fluctuations for OCEA.Check CASIF's competition here

Ocean Biomedical, Inc. (PNK: OCEA) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OCEA stands at 237.3K. In comparison, AFMDQ has a market cap of 1.6K. Regarding current trading prices, OCEA is priced at $0.00 on the PNK, while AFMDQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OCEA currently has a P/E ratio of N/A, whereas AFMDQ's P/E ratio is N/A. In terms of profitability, OCEA's ROE is +0.04%, compared to AFMDQ's ROE of -1.01%. Regarding short-term risk, OCEA is more volatile compared to AFMDQ. This indicates higher risk in terms of short-term price fluctuations for OCEA.Check AFMDQ's competition here

Ocean Biomedical, Inc. (PNK: OCEA) plays a significant role within the Healthcare sector. Its performance on the PNK reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OCEA stands at 237.3K. In comparison, BIORQ has a market cap of 905. Regarding current trading prices, OCEA is priced at $0.00 on the PNK, while BIORQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OCEA currently has a P/E ratio of N/A, whereas BIORQ's P/E ratio is N/A. In terms of profitability, OCEA's ROE is +0.04%, compared to BIORQ's ROE of +1.22%. Regarding short-term risk, OCEA is more volatile compared to BIORQ. This indicates higher risk in terms of short-term price fluctuations for OCEA.Check BIORQ's competition here